"Future outbreaks are inevitable. How do we ensure that research systems are in place and work when we next need them? In 2022, when the global outbreak of mpox emerged, clinical trialists had new tools for rapid rollout of trials; however, the system failed another stress test. In this Viewpoint, we highlight areas for improving implementation of future epidemic clinical trials"